LAB
Income statement / Annual
Last year (2025), Standard BioTools Inc's total revenue was $85.33 M,
a decrease of 51.08% from the previous year.
In 2025, Standard BioTools Inc's net income was -$74.90 M.
See Standard BioTools Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$85.33 M |
$174.43 M |
$106.34 M |
$97.95 M |
$130.58 M |
$138.14 M |
$117.24 M |
$112.96 M |
$101.94 M |
$104.45 M |
| Cost of Revenue |
$42.79 M
|
$90.17 M
|
$55.89 M
|
$60.90 M
|
$61.21 M
|
$54.82 M
|
$52.96 M
|
$51.32 M
|
$49.96 M
|
$46.01 M
|
| Gross Profit |
$42.54 M
|
$84.26 M
|
$50.45 M
|
$37.05 M
|
$69.37 M
|
$83.33 M
|
$64.28 M
|
$61.65 M
|
$51.98 M
|
$58.44 M
|
| Gross Profit Ratio |
0.5
|
0.48
|
0.47
|
0.38
|
0.53
|
0.6
|
0.55
|
0.55
|
0.51
|
0.56
|
| Research and Development Expenses |
$25.99 M
|
$62.41 M
|
$25.95 M
|
$37.38 M
|
$37.94 M
|
$36.46 M
|
$31.64 M
|
$30.03 M
|
$30.83 M
|
$38.42 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$109.86 M
|
$156.61 M
|
$87.54 M
|
$102.29 M
|
$98.89 M
|
$97.90 M
|
$84.48 M
|
$79.78 M
|
$79.52 M
|
$93.21 M
|
| Other Expenses |
$0.00
|
$40.48 M
|
$13.56 M
|
$13.59 M
|
$0.00
|
$0.00
|
$0.00
|
$637.00 K
|
$385.00 K
|
-$1.17 M
|
| Operating Expenses |
$135.85 M
|
$259.50 M
|
$127.05 M
|
$153.26 M
|
$136.83 M
|
$134.36 M
|
$116.12 M
|
$109.81 M
|
$110.34 M
|
$131.63 M
|
| Cost And Expenses |
$178.64 M
|
$349.67 M
|
$182.94 M
|
$214.15 M
|
$198.04 M
|
$189.18 M
|
$169.08 M
|
$161.13 M
|
$160.30 M
|
$177.64 M
|
| Interest Income |
$9.18 M
|
$20.20 M
|
$5.57 M
|
$2.23 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$26.00 K
|
$3.32 M
|
$4.57 M
|
$4.33 M
|
$3.82 M
|
$3.57 M
|
$4.28 M
|
$13.89 M
|
$5.82 M
|
$5.82 M
|
| Depreciation & Amortization |
$6.98 M
|
$16.86 M
|
$15.18 M
|
$15.03 M
|
$15.57 M
|
$15.92 M
|
$15.81 M
|
$16.50 M
|
$18.30 M
|
$17.94 M
|
| EBITDA |
-$89.69 M |
-$118.14 M |
-$54.46 M |
-$173.57 M |
-$44.27 M |
-$34.61 M |
-$46.62 M |
-$31.03 M |
-$39.68 M |
-$56.42 M |
| EBITDA Ratio |
-1.05
|
-0.68
|
-0.51
|
-1.77
|
-0.34
|
-0.25
|
-0.4
|
-0.27
|
-0.39
|
-0.54
|
| Operating Income Ratio |
-1.09
|
-1
|
-0.72
|
-1.19
|
-0.52
|
-0.37
|
-0.44
|
-0.43
|
-0.57
|
-0.7
|
| Total Other Income/Expenses Net |
-$3.40 M
|
$36.92 M
|
$2.40 M
|
-$76.72 M
|
$3.80 M
|
-$3.07 M
|
-$14.87 M
|
-$13.26 M
|
-$5.44 M
|
-$6.99 M
|
| Income Before Tax |
-$96.70 M
|
-$138.31 M
|
-$74.20 M
|
-$192.93 M
|
-$63.66 M
|
-$54.10 M
|
-$66.71 M
|
-$61.42 M
|
-$63.80 M
|
-$80.18 M
|
| Income Before Tax Ratio |
-1.13
|
-0.79
|
-0.7
|
-1.97
|
-0.49
|
-0.39
|
-0.57
|
-0.54
|
-0.63
|
-0.77
|
| Income Tax Expense |
-$37.88 M
|
$573.00 K
|
$452.00 K
|
-$2.83 M
|
-$4.42 M
|
-$1.08 M
|
-$1.92 M
|
-$2.41 M
|
-$3.26 M
|
-$4.19 M
|
| Net Income |
-$74.90 M
|
-$138.89 M
|
-$74.66 M
|
-$190.10 M
|
-$59.24 M
|
-$53.02 M
|
-$64.79 M
|
-$59.01 M
|
-$60.54 M
|
-$75.99 M
|
| Net Income Ratio |
-0.88
|
-0.8
|
-0.7
|
-1.94
|
-0.45
|
-0.38
|
-0.55
|
-0.52
|
-0.59
|
-0.73
|
| EPS |
-0.2 |
-0.52 |
-0.94 |
-2.43 |
-0.78 |
-0.74 |
-0.97 |
-1.49 |
-1.84 |
-2.62 |
| EPS Diluted |
-0.2 |
-0.52 |
-0.94 |
-2.43 |
-0.78 |
-0.74 |
-0.97 |
-1.49 |
-1.84 |
-2.62 |
| Weighted Average Shares Out |
$381.62 M
|
$352.67 M
|
$79.16 M
|
$78.31 M
|
$75.79 M
|
$72.04 M
|
$66.78 M
|
$39.65 M
|
$32.98 M
|
$29.01 M
|
| Weighted Average Shares Out Diluted |
$381.62 M
|
$352.67 M
|
$79.16 M
|
$78.31 M
|
$75.79 M
|
$72.04 M
|
$66.78 M
|
$39.65 M
|
$32.98 M
|
$29.01 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
